Download Files:
Products Details
Product Description
– KRAS G12C inhibitor 13 is a KRAS G12C inhibitor extracted from patent WO2018143315A1, compound 30[1].
Web ID
– HY-126292
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C40H46F3N7O4
References
– [1]KURAMOTO, Kazuyuki, et al. Quinazoline compound. WO2018143315A1.
CAS Number
– 2241719-75-3
Molecular Weight
– 745.83
SMILES
– C=CC(C(C1=C(C=NN2)C2=CC=C1C)=C3OCC(F)(F)F)=CC4=C3N=C(OC5CCN(C6CCOCC6)CC5)N=C4N7CCC8(CN(C(C=C)=O)C8)CC7
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Ras
Isoform
– K-Ras
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
